MECOM and chronic myelogenous leukemia, BCR-ABL1 positive: In addition to the expanded bulk of CML BM cells, Evi1+/GFPBCR–ABLtg/− mice showed an increase in GFP intensity and the number of LSK cells (Supplementary Figures S2a and S3c).